Stockscreener 앱 받기
215.89
1.85%
3.93
시간 외 거래:
215.89
Abbvie Inc 주식(ABBV)의 최신 뉴스
AbbVie (NYSE:ABBV) Shares Up 1.9% After Analyst Upgrade - MarketBeat
AbbVie Inc. SEC 10-Q Report - TradingView
AbbVie (ABBV) Receives a Buy from BMO Capital - The Globe and Mail
Schwab U.S. Dividend Equity ETF (SCHD) Offers Higher Yield and Lower Fees Than ProShares S&P 500 Dividend Aristocrats ETF (NOBL) - The Motley Fool
Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain ShiftsGlobal Forecast to 2034 - Yahoo Finance
Bernstein raises AbbVie stock price target to $225 on long-term growth - Investing.com Nigeria
Bernstein Adjusts Price Target on AbbVie to $225 From $203, Maintains Market Perform Rating - MarketScreener
AbbVie (NYSE:ABBV) Downgraded to "Hold" Rating by DZ Bank - MarketBeat
AbbVie Inc. (NYSE:ABBV) Q3 2025 Earnings Call Transcript - Insider Monkey
Here Are Tuesday's Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More - 24/7 Wall St.
Tufton Capital Management Has $10.25 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Magnolia Capital Advisors LLC Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Huntington National Bank Has $125.30 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
EPG Wealth Management LLC Sells 2,439 Shares of AbbVie Inc. $ABBV - MarketBeat
Can AbbVie Inc. (Common Stock) (4AB0) stock retain market dominance2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com
Colorado Judge Denies AbbVie's Bid To Block State Drug Law - Law360
AbbVie (NYSE:ABBV) Stock Price Down 2.8%Here's Why - MarketBeat
Citigroup Lowers Price Target for AbbVie (ABBV) to $235 Amidst N - GuruFocus
AbbVie, Novartis Win Block of Oklahoma Drug Discount Law - Bloomberg Law News
The AbbVie Decision and the Economics of Corporate Control Markets - The National Law Review
Do Wall Street Analysts Like AbbVie Stock? - Barchart.com
JP Morgan Raises Price Target on AbbVie (ABBV) to $260, Maintains Overweight Rating | ABBV Stock News - GuruFocus
What Wall Street predicts for AbbVie Inc. stock pricePortfolio Gains Summary & Technical Confirmation Trade Alerts - newser.com
ABBV Q3 Deep Dive: Immunology Growth and Pipeline Expansion Offset Margin Pressure - TradingView
Here’s What Drove Baron Health Care Fund to Add AbbVie (ABBV) to Its Portfolio - Insider Monkey
Goldman Sachs Adjusts Price Target on AbbVie to $223 From $218 - MarketScreener
Analyst on AbbVie (ABBV): ‘Stay Long’ - Insider Monkey
Obermeyer Wealth Partners Sells 12,006 Shares of AbbVie Inc. $ABBV - MarketBeat
Bank of New York Mellon Corp Cuts Position in AbbVie Inc. $ABBV - MarketBeat
Street View: Immunology strength holds at AbbVie despite aesthetics drag - TradingView
AbbVie Inc. $ABBV Shares Acquired by Machina Capital S.A.S. - MarketBeat
AbbVie Inc. $ABBV Holdings Lifted by Tsfg LLC - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Bank of Montreal Can - MarketBeat
Raymond James raises Abbvie stock price target to $256 on solid growth - Investing.com Nigeria
AbbVie Inc. $ABBV Shares Sold by Texas Bank & Trust Co - MarketBeat
Torray Investment Partners LLC Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
Raymond James Adjusts Price Target on AbbVie to $256 From $250, Maintains Outperform Rating - MarketScreener
JPMorgan Adjusts Price Target on AbbVie to $260 From $250, Maintains Overweight Rating - MarketScreener
BNP Paribas Exane Adjusts Price Target on AbbVie to $203 From $197, Maintains Neutral Rating - MarketScreener
Burney Co. Has $11.59 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Is AbbVie Inc. stock undervalued at current priceGap Up & High Accuracy Investment Entry Signals - newser.com
Sigma Planning Corp Sells 4,396 Shares of AbbVie Inc. $ABBV - MarketBeat
United States Multiple Myeloma Market Research Report 2025-2033, Profiles of Key PlayersNovartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, Takeda, and Bristol-Myers Squibb - GlobeNewswire
Is AbbVie Inc. stock resilient to inflation2025 Macro Impact & Capital Protection Trading Alerts - newser.com
Will AbbVie Inc. (Common Stock) (4AB0) stock test record highs in 2025Market Risk Analysis & High Return Stock Watch Alerts - newser.com
Targeted Drug Delivery Market Set to Witness Massive Growth - openPR.com
Can AbbVie Inc. stock retain market dominanceJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - newser.com
Will AbbVie Inc. stock attract more institutional investorsJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
Will AbbVie Inc. stock beat EPS estimatesProduct Launch & Real-Time Stock Movement Alerts - newser.com
Why AbbVie Inc. (4AB) stock stays on top picks2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
How to recover losses in AbbVie Inc. stockWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Is AbbVie Inc. (4AB) stock undervalued after correctionWeekly Stock Summary & Capital Efficient Trading Techniques - newser.com
Reversal indicators forming on AbbVie Inc. stockEarnings Trend Report & Real-Time Buy Signal Alerts - newser.com
State of Michigan Retirement System Buys 1,400 Shares of AbbVie Inc. $ABBV - MarketBeat
Nicholas Company Inc. Cuts Holdings in AbbVie Inc. $ABBV - MarketBeat
Tredje AP fonden Cuts Position in AbbVie Inc. $ABBV - MarketBeat
Triglav Investments D.O.O. Lowers Stake in AbbVie Inc. $ABBV - MarketBeat
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Boosts Stock Position in AbbVie Inc. $ABBV - MarketBeat
TIAA Trust National Association Sells 10,325 Shares of AbbVie Inc. $ABBV - MarketBeat
Welch & Forbes LLC Cuts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Great Lakes Retirement Inc. - MarketBeat
Why AbbVie Stock Flopped on Friday - AOL.com
AbbVie (ABBV) Surpasses Q3 Expectations with Strong Revenue Grow - GuruFocus
Earnings Scorecard: 24 out of 25 healthcare firms deliver EPS wins this week - Seeking Alpha
ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat - MSN
0.32%
1.75%
자본화:
|
볼륨(24시간):